NK
NKGen Biotech, Inc. Warrants
NKGNW · NASDAQ
$0.03 +2,408.33% (+$0.03)
Market Cap $6.18M
P/E Ratio -
Div. Yield -
ROE 103.10%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 9.48x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 4,135.89%
Gross margin 0.00%
FCF margin 3,202.61%
Quality
75 /100
Excellent Asset turnover 27.17x
ROE 103.10%
ROA 184,525.00%
Debt
64 /100
Moderate Net debt/EBITDA 0.00x
Int. coverage 0.00x
Debt/Assets N/A
Stability
37 /100
Moderate Profitable years 0
Beta 0.64x
EPS volatility 211.35%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NKGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Y. Song
Employees
63
Headquarters
Santa Ana